Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Opioids Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global opioids market reached a value of US$ XX Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Opioids are drugs used to control persistent and severe pain among patients suffering from chronic headaches and backaches. They interact with proteins in the brain, spinal cord, gut, and other parts of the body to block pain signals. They are either extracted from the poppy seeds or synthesized in the laboratory. They are generally available in the form of pills or as lozenges. They can also be administered into the vein via an intravenous (IV) injection or infusion and taken through oral and transdermal routes, wherein active ingredients are delivered across the skin for systemic distribution.

Opioids Market Trends:

The rising prevalence of cancer on account of excessive tobacco and alcohol consumption and the occurrence of obesity, human papillomavirus (HPV), and multiple sunburns worldwide represents one of the key factors bolstering the market growth. This can also be attributed to the increasing geriatric population and the growing risk of developing cancer with age. Moreover, the rising number of individuals undergoing surgical interventions is positively influencing the sales of opioids across the globe as they help control post-surgical pain, speed recovery, and reduce the chances of complications, such as pneumonia and blood clots. Apart from this, the growing participation of children in professional sports and physical activities has led to an increase in the incidents of severe injuries. This, in confluence with the rising awareness among parents about the physical health of their children, is escalating the demand for opioids to manage severe pain. Furthermore, increasing investments in research and development (R&D) activities to assess the efficacy and safety of opioids in new diseases are projected to drive the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global opioids market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product type, application and distribution channel.

Breakup by Product Type:

  • Codeine 
  • Fentanyl
  • Methadone
  • Oxycodone
  • Morphine
  • Hydrocodone
     

Breakup by Application:

  • Pain Management
  • Cough Treatment
  • Diarrhea Treatment
  • Others
     

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Stores
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Boehringer Ingelheim International GmbH, Hikma Pharmaceuticals PLC, Mallinckrodt plc, Pfizer Inc., Purdue Pharma L.P., Sanofi S.A., Sun Pharmaceutical Industries Ltd. and Teva Pharmaceutical Industries Ltd.

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
    Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Product Type, Application, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Boehringer Ingelheim International GmbH, Hikma Pharmaceuticals PLC, Mallinckrodt plc, Pfizer Inc., Purdue Pharma L.P., Sanofi S.A., Sun Pharmaceutical Industries Ltd. and Teva Pharmaceutical Industries Ltd.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global opioids market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global opioids market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global opioids market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Opioids Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product Type
    6.1    Codeine 
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Fentanyl
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Methadone
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Oxycodone
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Morphine
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Hydrocodone
        6.6.1 Market Trends
        6.6.2 Market Forecast
7    Market Breakup by Application
    7.1    Pain Management
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Cough Treatment
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Diarrhea Treatment
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Others
        7.4.1 Market Trends
        7.4.2 Market Forecast
8    Market Breakup by Distribution Channel
    8.1    Hospital Pharmacies
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Retail Pharmacies
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Drug Stores
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Online Stores
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Others
        8.5.1 Market Trends
        8.5.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Boehringer Ingelheim International GmbH
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
        14.3.2    Hikma Pharmaceuticals PLC
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Mallinckrodt plc
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
        14.3.4    Pfizer Inc.
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Purdue Pharma L.P.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
        14.3.6    Sanofi S.A.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Sun Pharmaceutical Industries Ltd. 
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    Teva Pharmaceutical Industries Ltd.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis

List of Figures

Figure 1: Global: Opioids Market: Major Drivers and Challenges
Figure 2: Global: Opioids Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Opioids Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Opioids Market: Breakup by Product Type (in %), 2020
Figure 5: Global: Opioids Market: Breakup by Application (in %), 2020
Figure 6: Global: Opioids Market: Breakup by Distribution Channel (in %), 2020
Figure 7: Global: Opioids Market: Breakup by Region (in %), 2020
Figure 8: Global: Opioids (Codeine) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Opioids (Codeine) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Opioids (Fentanyl) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Opioids (Fentanyl) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Opioids (Methadone) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Opioids (Methadone) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Opioids (Oxycodone) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Opioids (Oxycodone) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Opioids (Morphine) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Opioids (Morphine) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Opioids (Hydrocodone) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Opioids (Hydrocodone) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Opioids (Pain Management) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Opioids (Pain Management) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Opioids (Cough Treatment) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Opioids (Cough Treatment) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Opioids (Diarrhea Treatment) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Opioids (Diarrhea Treatment) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Opioids (Other Applications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Opioids (Other Applications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Global: Opioids (Hospital Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Global: Opioids (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Global: Opioids (Retail Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Global: Opioids (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Global: Opioids (Drug Stores) Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Global: Opioids (Drug Stores) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: Global: Opioids (Online Stores) Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: Global: Opioids (Online Stores) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Global: Opioids (Other Distribution Channels) Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Global: Opioids (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: North America: Opioids Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: North America: Opioids Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: United States: Opioids Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: United States: Opioids Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Canada: Opioids Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Canada: Opioids Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Asia-Pacific: Opioids Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Asia-Pacific: Opioids Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: China: Opioids Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: China: Opioids Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Japan: Opioids Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Japan: Opioids Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: India: Opioids Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: India: Opioids Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: South Korea: Opioids Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: South Korea: Opioids Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: Australia: Opioids Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: Australia: Opioids Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Indonesia: Opioids Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Indonesia: Opioids Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: Others: Opioids Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: Others: Opioids Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: Europe: Opioids Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: Europe: Opioids Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Germany: Opioids Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Germany: Opioids Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: France: Opioids Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: France: Opioids Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: United Kingdom: Opioids Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: United Kingdom: Opioids Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Italy: Opioids Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Italy: Opioids Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Spain: Opioids Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Spain: Opioids Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: Russia: Opioids Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: Russia: Opioids Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Others: Opioids Market: Sales Value (in Million US$), 2015 & 2020
Figure 75: Others: Opioids Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: Latin America: Opioids Market: Sales Value (in Million US$), 2015 & 2020
Figure 77: Latin America: Opioids Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 78: Brazil: Opioids Market: Sales Value (in Million US$), 2015 & 2020
Figure 79: Brazil: Opioids Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 80: Mexico: Opioids Market: Sales Value (in Million US$), 2015 & 2020
Figure 81: Mexico: Opioids Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 82: Others: Opioids Market: Sales Value (in Million US$), 2015 & 2020
Figure 83: Others: Opioids Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 84: Middle East and Africa: Opioids Market: Sales Value (in Million US$), 2015 & 2020
Figure 85: Middle East and Africa: Opioids Market: Breakup by Country (in %), 2020
Figure 86: Middle East and Africa: Opioids Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 87: Global: Opioids Industry: SWOT Analysis
Figure 88: Global: Opioids Industry: Value Chain Analysis
Figure 89: Global: Opioids Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Opioids Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Opioids Market Forecast: Breakup by Product Type (in Million US$), 2021-2026
Table 3: Global: Opioids Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 4: Global: Opioids Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 5: Global: Opioids Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Opioids Market: Competitive Structure
Table 7: Global: Opioids Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links